Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Setchell, K. D. R.
Right arrow Articles by Cole, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Setchell, K. D. R.
Right arrow Articles by Cole, S. J.
© 2006 American Society for Nutrition J. Nutr. 136:2188-2193, August 2006


Nutrient Physiology, Metabolism, and Nutrient-Nutrient Interactions

Method of Defining Equol-Producer Status and Its Frequency among Vegetarians1,2

Kenneth D. R. Setchell3,4,* and Sidney J. Cole5

3 Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229; 4 Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229; and 5 Sanitarium Development and Innovation, Cooranbong, NSW 2265, Australia

* To whom correspondence should be addressed. E-mail: kenneth.setchell{at}cchmc.org.

7-Hydroxy-3-(4'-hydroxyphenyl)-chroman (S-equol) is a specific end-metabolite formed in the biotransformation of the dietary soy isoflavones daidzin and daidzein by intestinal bacteria. The frequency of equol production varies among individuals and populations, and it is suggested that the efficacy of soy foods differs depending on the ability of an individual to produce equol. To develop a standardized approach to define equol-producer status that can be universally adopted to differentiate these 2 distinct populations, we measured isoflavones in serum and urine collected from a cohort of 41 healthy adults, comprising 29 vegetarians and 12 nonvegetarians, after consuming 2 x 250 mL/d soy milk on 3 consecutive days. Serum and urinary daidzein and S-equol concentrations were analyzed by MS. Serum S-equol and daidzein concentrations ranged from 10.3–139 nmol/L (2.5–33.6 µg/L) and 16–1401 nmol/L (4.0–356 µg/L), respectively, whereas in urine the corresponding concentrations ranged from 16–12,574 nmol/L (4–3043 µg/L) and 539–26,834 nmol/L (137–6816 µg/L), respectively. The log10-transformed urinary S-equol:daidzein ratio provided a clearer distinction of equol-producer status than the absolute serum or urinary S-equol concentrations because it is independent of isoflavone intake and minimizes interindividual variation in isoflavone pharmacokinetics or differences in analytical methodologies. A threshold value for the log10-transformed urinary S-equol:daidzein ratio of –1.75 provided a demarcation to define equol-producer status. The frequency of equol producers in the vegetarians was 59%, similar to the reported frequency in Japanese adults consuming soy, and much higher than for nonvegetarian adults (25%), suggesting that dietary components other than soy influence S-equol synthesis by intestinal bacteria.





This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
C. Atkinson, K. M Newton, E. J A. Bowles, M. Yong, and J. W Lampe
Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States
Am. J. Clinical Nutrition, March 1, 2008; 87(3): 679 - 687.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. Brink, V. Coxam, S. Robins, K. Wahala, A. Cassidy, F. Branca, and on behalf of the PHYTOS Investigators
Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study
Am. J. Clinical Nutrition, March 1, 2008; 87(3): 761 - 770.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
B. J. Fuhrman, B. E. Teter, M. Barba, C. Byrne, A. Cavalleri, B. J. Grant, P. J. Horvath, D. Morelli, E. Venturelli, and P. C. Muti
Equol Status Modifies the Association of Soy Intake and Mammographic Density in a Sample of Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 33 - 42.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. Bolca, S. Possemiers, A. Herregat, I. Huybrechts, A. Heyerick, S. De Vriese, M. Verbruggen, H. Depypere, D. De Keukeleire, M. Bracke, et al.
Microbial and Dietary Factors Are Associated with the Equol Producer Phenotype in Healthy Postmenopausal Women
J. Nutr., October 1, 2007; 137(10): 2242 - 2246.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Clerici, K. D. R. Setchell, P. M. Battezzati, M. Pirro, V. Giuliano, S. Asciutti, D. Castellani, E. Nardi, G. Sabatino, S. Orlandi, et al.
Pasta Naturally Enriched with Isoflavone Aglycons from Soy Germ Reduces Serum Lipids and Improves Markers of Cardiovascular Risk
J. Nutr., October 1, 2007; 137(10): 2270 - 2278.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]